Pharma M&A versus alliances and its underlying value drivers

Are M&A or alliances the right therapy for an ailing pharmaceutical industry?- A capital market perspective

Heiko Schön author Dirk Schiereck editor

Format:Hardback

Publisher:Peter Lang AG

Published:28th Sep '15

Currently unavailable, and unfortunately no date known when it will be back

Pharma M&A versus alliances and its underlying value drivers cover

From a capital market perspective, the author analyzes Merger and Acquisitions transactions (M&A) and in-licensings in the pharmaceutical industry between 1998 and 2012. Utilizing the event study methodology, the volume shows that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. But what are the underlying value drivers which make a deal a success or a failure story? The author derives significant innovative determinants of success for both strategies.

ISBN: 9783631663813

Dimensions: unknown

Weight: 360g

201 pages

New edition